nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
|
Bevan, David H. |
|
2009 |
124 |
S2 |
p. S12-S16 5 p. |
artikel |
2 |
Half-life extension through albumin fusion technologies
|
Schulte, Stefan |
|
2009 |
124 |
S2 |
p. S6-S8 3 p. |
artikel |
3 |
Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency
|
Peyvandi, Flora |
|
2009 |
124 |
S2 |
p. S9-S11 3 p. |
artikel |
4 |
Treatment of congenital bleeding disorders: future trends in management ‡ ‡ Proceedings from the CSL Behring-sponsored symposium, held at the XXII Congress of the International Society on Thrombosis and Haemostasis, Boston, USA, 15 July 2009
|
DiMichele, Donna |
|
2009 |
124 |
S2 |
p. S1- 1 p. |
artikel |
5 |
Visions in haemophilia care
|
Pipe, Steven |
|
2009 |
124 |
S2 |
p. S2-S5 4 p. |
artikel |